Please click here to read about our careful return to care.

alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

An amniotic membrane is used to repair and heal damaged eye surfaces such as severe medical burns, dry eye disease, and many other ocular surface irregularities. The membrane acts as a physical barrier to protect conjunctival and corneal epithelium as it heals, and it reduces pain caused by friction of the eyelids over the surface. In addition, the amniotic membrane promotes epithelial growth through cell migration, adhesion, and differentiation, while also inhibiting cell death.


PROKERA is made by clipping a piece of amniotic membrane tissue in between two rings made out of a clear, flexible material.

BioDOptix is a dehydrated, extracellular membrane tissue that is applied after the ocular surface is completely dry. BioDOptix a flat disc of tissue without a stabilizing outer ring.


PROKERA & BioDOptix are therapeutic lenses are cleared by the FDA to reduce inflammation and simultaneously promote regenerative healing of the ocular surface.  Amniotic membranes are harvested in a sterile environment from placental tissue obtained during elective cesarean sections. Donors are screened for transmissible diseases.